Literature DB >> 8926502

Did de novo MELAS common mitochondrial DNA point mutation (mtDNA 3243, A-->G transition) occur in the mother of a proband of a Japanese MELAS pedigree?

M Yamamoto1.   

Abstract

MELAS is a major maternally inherited mitochondrial (mt) encephalomyopathy of which 80% of cases are associated with mtDNA point mutation (mtDNA 3243, A-->G transition) which exists under heteroplasmic conditions with wild-type mtDNA. The origin of this mutation remains obscure in the reported pedigrees. I analyzed this mutation in a Japanese MELAS pedigree by PCR. The proband had typical MELAS features. The proband's mother was oligosymptomatic (fatigability, nerve deafness and diabetes mellitus). The proband's maternal grandmother was diagnosed as having senile dementia of the Alzheimer type clinically. The brother of the proband's mother was healthy. The ratios of this mutation in muscle and leukocytes of the proband and his mother were 89%, 36%, 79% and 10%, respectively. There were no mutations in muscle and leukocytes of the proband's maternal grandmother and his mother's brother. These results showed the possibility that this mutation occurred in the proband's mother.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8926502     DOI: 10.1016/0022-510x(95)00272-4

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  4 in total

1.  De Novo Mutation of m.3243A>G together with m.16093T>C Associated with Atypical Clinical Features in a Pedigree with MIDD Syndrome.

Authors:  Zhixin Jiang; Yinan Zhang; Jingbin Yan; Fengwen Li; Xinqian Geng; Huijuan Lu; Xiaoer Wei; Yanmei Feng; Congrong Wang; Weiping Jia
Journal:  J Diabetes Res       Date:  2019-04-04       Impact factor: 4.011

2.  Three families with 'de novo' m.3243A > G mutation.

Authors:  Paul de Laat; Mirian C H Janssen; Charlotte L Alston; Robert W Taylor; Richard J T Rodenburg; Jan A M Smeitink
Journal:  BBA Clin       Date:  2016-04-29

3.  De novo mtDNA point mutations are common and have a low recurrence risk.

Authors:  Suzanne C E H Sallevelt; Christine E M de Die-Smulders; Alexandra T M Hendrickx; Debby M E I Hellebrekers; Irenaeus F M de Coo; Charlotte L Alston; Charlotte Knowles; Robert W Taylor; Robert McFarland; Hubert J M Smeets
Journal:  J Med Genet       Date:  2016-07-22       Impact factor: 6.318

4.  The first concurrent detection of mitochondrial DNA m.3243A>G mutation, deletion, and depletion in a family with mitochondrial diabetes.

Authors:  Mouna Tabebi; Wajdi Safi; Rahma Felhi; Olfa Alila Fersi; Leila Keskes; Mohamed Abid; Mouna Mnif; Faiza Fakhfakh
Journal:  Mol Genet Genomic Med       Date:  2020-05-11       Impact factor: 2.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.